Julian Heslop
Plus aucun poste en cours
Fortune : 65 405 $ au 31/03/2024
Profil
Julian Spenser Heslop formerly worked at ViiV Healthcare Ltd., as Chairman, Genelabs Technologies, Inc., as Chief Financial Officer & Executive Director, GSK Plc, as Chief Financial Officer & Executive Director in 2011, Dechra Pharmaceuticals Plc, as Independent Non-Executive Director from 2013 to 2022, The Royal Academy of Arts, as Director, Itaconix Plc, as Independent Non-Executive Director from 2012 to 2018, Glaxo Wellcome Plc, as Financial Controller from 1998 to 2000, Grand Metropolitan Plc, as Controller, and Stoy Hayward Ltd., as Auditor in 1979.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NORTHERN 2 VCT PLC
0,05% | 01/02/2024 | 95 000 ( 0,05% ) | 65 405 $ | 31/03/2024 |
Anciens postes connus de Julian Heslop
| Sociétés | Poste | Fin |
|---|---|---|
| DECHRA PHARMACEUTICALS | Director/Board Member | 05/09/2022 |
| ITACONIX PLC | Director/Board Member | 02/10/2018 |
| GSK PLC | Director of Finance/CFO | 31/03/2011 |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Chairman | 01/03/2011 |
| Glaxo Wellcome Plc | Comptroller/Controller/Auditor | 01/01/2000 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GSK PLC | Health Technology |
| DECHRA PHARMACEUTICALS | Health Technology |
| ITACONIX PLC | Process Industries |
| Entreprise privées | 6 |
|---|---|
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
| Grand Metropolitan Plc | Consumer Non-Durables |
| Stoy Hayward Ltd. | Commercial Services |
The Royal Academy of Arts
 The Royal Academy of Arts Miscellaneous Commercial ServicesCommercial Services The Royal Academy of Arts, founded in 1768, is an artist-led organization that champions art and artists. The academy is located in Piccadilly, UK, and has subsidiaries in the United Kingdom. The academy's collection tells the story of leading artists and architects, and it offers a range of free activities and resources to support teachers, students, and young people to engage with art and artists. The academy hosts the Summer Exhibition every year since 1769, displaying works in a variety of mediums and genres by emerging and established artists. The academy also offers artist-led workshops, galleries full of art and architecture, and at-home art activities for families, and kids under 16 go free to all exhibitions. | Commercial Services |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
